泰合健康（Theranos）是一家美国的生物技术公司，成立于2003年。由伊丽莎白·霍姆斯（Elizabeth Holmes）创办，该公司以其所称的革命性验血技术而受到广泛关注。然而，2016年，泰合健康陷入了重大的丑闻，并随后被曝出存在欺诈行为。随着多项指控和调查的涌现，该公司最终停止了交易，并从股票市场上撤出。

Theranos was a U.S. biotechnology company founded by Elizabeth Holmes in 2003. The company gained widespread attention for its claimed revolutionary blood testing technology. However, in 2016, Theranos became embroiled in a major scandal and was subsequently exposed for engaging in fraudulent activities. With multiple allegations and investigations emerging, the company eventually halted trading and withdrew from the stock market.

泰合健康声称其测试技术可以通过仅采集少量的血液样本来进行全面化验，这将为人们提供更方便、快速和准确的医疗结果。然而，后来的调查发现，这些宣称的技术并不存在，且公司使用了传统的血液测试方法来进行分析。此外，一些前员工还揭示了公司内部存在的欺诈行为和不当操作。

Theranos claimed that its testing technology could perform comprehensive analyses with just a small amount of blood sample, providing people with convenient, quick, and accurate medical results. However, subsequent investigations revealed that the claimed technology did not exist, and the company was using conventional blood testing methods for analysis. Furthermore, some former employees exposed fraudulent practices and improper operations within the company.

这一大规模的欺诈行为导致了泰合健康的信誉彻底崩溃。公司的价值被大幅低估，投资者纷纷撤资并寻求法律救济。美国证券交易委员会（SEC）对该公司提起了诉讼，指控其在募资过程中欺诈了投资者，并以虚假陈述误导市场。此外，伊丽莎白·霍姆斯本人也面临了法律的追究。

This massive fraud led to the complete collapse of Theranos' reputation. The company's value was severely underestimated, and investors withdrew their funds and sought legal remedies. The U.S. Securities and Exchange Commission (SEC) filed a lawsuit against the company, accusing it of defrauding investors during fundraising and misleading the market with false statements. Additionally, Elizabeth Holmes herself faced legal scrutiny.

随着丑闻不断发酵，泰合健康最终停止了交易，并退出了股票市场。这也意味着该公司无力再进行正常的运营和发展。对于投资者和员工来说，这无疑是一次巨大的打击，他们不仅失去了投资和工作机会，还遭受了信任和声誉的严重损害。

As the scandal continued to unfold, Theranos ultimately halted trading and withdrew from the stock market. This also meant that the company was no longer able to operate and grow in a normal manner. For investors and employees, this was undoubtedly a huge blow, as they not only lost their investments and job opportunities but also suffered severe damage to trust and reputation.

泰合健康的倒闭引发了人们对生物技术行业监管的讨论。此事件揭示了监管机构审查新兴技术公司的重要性，以降低市场中欺诈和虚假宣传的风险。同时，这也提醒了投资者和消费者要保持谨慎，审慎评估公司的声誉和技术可行性，以免陷入类似的欺诈陷阱。

The collapse of Theranos prompted discussions on the regulation of the biotechnology industry. This event highlighted the importance of regulatory agencies scrutinizing emerging technology companies to mitigate the risks of fraud and false advertising in the market. At the same time, it reminded investors and consumers to exercise caution and carefully assess a company's reputation and technological feasibility to avoid falling into similar fraudulent traps.

In conclusion, Theranos' suspension of trading and withdrawal from the stock market was a result of the company's involvement in a major scandal and fraudulent activities. The incident served as a stark reminder of the importance of regulatory oversight in the biotechnology industry and the need for investors and consumers to be vigilant in assessing the credibility and feasibility of companies before investing or engaging in their services.

总结：泰合健康（Theranos）因涉及重大丑闻和欺诈行为而停止交易并退出股票市场。该事件提醒了人们在投资和选择服务时要保持警惕，审慎评估公司的可信度和可行性。同时，它也突显了生物技术行业监管的重要性，以减少市场中的欺诈风险。